769 related articles for article (PubMed ID: 18480417)
21. Optimal care of autosomal dominant polycystic kidney disease patients.
Schrier RW
Nephrology (Carlton); 2006 Apr; 11(2):124-30. PubMed ID: 16669974
[TBL] [Abstract][Full Text] [Related]
22. Progress in blood pressure control in autosomal dominant polycystic kidney disease.
Ecder T; Edelstein CL; Fick-Brosnahan GM; Johnson AM; Duley IT; Gabow PA; Schrier RW
Am J Kidney Dis; 2000 Aug; 36(2):266-71. PubMed ID: 10922304
[TBL] [Abstract][Full Text] [Related]
23. [Two cases of autosomal dominant polycystic kidney diseases who presented bilateral enlarged kidneys and severe hypertension in the neonatal period].
Wakaki H; Ikeda M; Hataya H; Ishikura K; Nakashima T; Oosako Y; Honda M
Nihon Jinzo Gakkai Shi; 2004 Oct; 46(7):719-23. PubMed ID: 15570901
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the development of renal hypertension in male and female rats.
Okuniewski R; Davis EA; Jarrott B; Widdop RE
Clin Sci (Lond); 1998 Oct; 95(4):445-51. PubMed ID: 9748420
[TBL] [Abstract][Full Text] [Related]
25. Endothelin B receptor blockade accelerates disease progression in a murine model of autosomal dominant polycystic kidney disease.
Chang MY; Parker E; El Nahas M; Haylor JL; Ong AC
J Am Soc Nephrol; 2007 Feb; 18(2):560-9. PubMed ID: 17202412
[TBL] [Abstract][Full Text] [Related]
26. Renal denervation attenuates long-term hypertensive effects of Angiotensin ii in the rat.
Hendel MD; Collister JP
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1225-30. PubMed ID: 17184505
[TBL] [Abstract][Full Text] [Related]
27. Renal nerves in hypertension.
Janssen BJ; Smits JF
Miner Electrolyte Metab; 1989; 15(1-2):74-82. PubMed ID: 2644526
[TBL] [Abstract][Full Text] [Related]
28. Autosomal dominant polycystic kidney disease: time for a change?
Chapman AB
J Am Soc Nephrol; 2007 May; 18(5):1399-407. PubMed ID: 17429048
[TBL] [Abstract][Full Text] [Related]
29. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats.
Cowley BD; Ricardo SD; Nagao S; Diamond JR
Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583
[TBL] [Abstract][Full Text] [Related]
30. Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.
De Almeida EA; Prata MM
Rev Port Cardiol; 2007 Nov; 26(11):1173-82. PubMed ID: 18297839
[TBL] [Abstract][Full Text] [Related]
31. Role of the renal nerves in gamma-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats.
Hayakawa K; Kimura M; Yamori Y
Eur J Pharmacol; 2005 Nov; 524(1-3):120-5. PubMed ID: 16256107
[TBL] [Abstract][Full Text] [Related]
32. Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat.
Winternitz SR; Katholi RE; Oparil S
J Clin Invest; 1980 Nov; 66(5):971-8. PubMed ID: 7000828
[TBL] [Abstract][Full Text] [Related]
33. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study.
Fick-Brosnahan GM; Belz MM; McFann KK; Johnson AM; Schrier RW
Am J Kidney Dis; 2002 Jun; 39(6):1127-34. PubMed ID: 12046022
[TBL] [Abstract][Full Text] [Related]
34. Autosomal dominant polycystic kidney disease and hypertension in the aviator.
Fox KA; Rudge FW
Aviat Space Environ Med; 1996 Apr; 67(4):376-8. PubMed ID: 8900993
[TBL] [Abstract][Full Text] [Related]
35. Hereditary error in epidermal growth factor prohormone metabolism in a rat model of autosomal dominant polycystic kidney disease.
Lakshmanan J; Eysselein V
Biochem Biophys Res Commun; 1993 Dec; 197(3):1083-93. PubMed ID: 8280123
[TBL] [Abstract][Full Text] [Related]
36. Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease.
Wu M; Wahl PR; Le Hir M; Wackerle-Men Y; Wuthrich RP; Serra AL
Kidney Blood Press Res; 2007; 30(4):253-9. PubMed ID: 17596700
[TBL] [Abstract][Full Text] [Related]
37. Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function.
Lee YR; Lee KB
Nephron Clin Pract; 2006; 103(4):c173-80. PubMed ID: 16636585
[TBL] [Abstract][Full Text] [Related]
38. Hypertension in autosomal dominant polycystic kidney disease.
Chapman AB; Gabow PA
Kidney Int Suppl; 1997 Oct; 61():S71-3. PubMed ID: 9328971
[No Abstract] [Full Text] [Related]
39. Hypertension in polycystic kidney disease without renal failure.
Nash DA
Arch Intern Med; 1977 Nov; 137(11):1571-5. PubMed ID: 921444
[TBL] [Abstract][Full Text] [Related]
40. Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide?
Devuyst O
J Nephrol; 2003; 16(3):449-52. PubMed ID: 12832751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
